Marshall Wace North America’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Marshall Wace North America’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,011	Closed	-$254K	–	1857
2021 Q1	$254K	Buy	+5,011	New	+$279K	﹤0.01%	1352
2019 Q3	–	Sell	-14,000	Closed	-$678K	–	1598
2019 Q2	$678K	Buy	+14,000	New	+$595K	﹤0.01%	835

Other funds holding SILK

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Marshall Wace North America's SILK Position: Q2 2021 in Review

Marshall Wace North America sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2021, closing a stake of 5,011 shares — an estimated $254K sold.

Marshall Wace North America first reported a position in SILK in Q2 2019 and held it in 2 quarters. The position peaked at $678K in Q2 2019. 155 funds tracked by Wall St. Rank hold SILK as of Q2 2021.

Marshall Wace North America reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Marshall Wace North America sold 5,011 Silk Road Medical, Inc. Common Stock shares in Q2 2021, an estimated $254K.
Marshall Wace North America first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
Marshall Wace North America's Silk Road Medical, Inc. Common Stock position peaked at $678K in Q2 2019.
155 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.